Your browser version may not work well with NCBI's Web applications. More information here...
1: Anticancer Res. 1999 Jan-Feb;19(1B):635-8.Links

Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).

Csatary LK, Moss RW, Beuth J, Töröcsik B, Szeberenyi J, Bakacs T.

United Cancer Research Institute, Alexandria, VA, USA.

Newcastle Disease Virus Vaccine (MTH-68/H) was administered to patients suffering from advanced neoplastic diseases after non-efficient tumor-destructive treatment. Case reports of selected patients suggest promising effects of this treatment. A prospectively-randomized clinical study (phase III; in accordance with Good Clinical Practice, GCP) was proposed to confirm these results and is currently under consideration.

PMID: 10216468 [PubMed - indexed for MEDLINE]